Tilman Lingscheid
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Antimicrobial Resistance in Staphylococcus
- COVID-19 Clinical Research Studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 5
- COVID-19 Clinical Research Studies 4
- Epidemiology 12
- Infective Endocarditis Diagnosis and Management 4
- Co-authors
- Heinz Burgmann (8 shared papers)Wolfgang Poeppl (7 shared papers)Selma Tobudic (4 shared papers)Roberto Plasenzotti (4 shared papers)Guido A. Gualdoni (2 shared papers)Nicolas Kozakowski (3 shared papers)Gerhard J. Zlabinger (1 shared paper)Peter Steinberger (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Journal of Travel Medicine (4 papers)Pharmacology (2 papers)Infection (2 papers)Scientific Reports (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Tilman Lingscheid
21 papers receiving 273 citations
Peers
Comparison fields: 5 of 69
- Molecular Medicine 52
- Infectious Diseases 114
- Applied Microbiology and Biotechnology 11
- Clinical Biochemistry 28
- Pharmacology 42
Countries citing papers authored by Tilman Lingscheid
This map shows the geographic impact of Tilman Lingscheid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Lingscheid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Lingscheid more than expected).
Fields of papers citing papers by Tilman Lingscheid
This network shows the impact of papers produced by Tilman Lingscheid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Lingscheid. The network helps show where Tilman Lingscheid may publish in the future.
Co-authors
The 25 scholars most cited alongside Tilman Lingscheid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 46 | |
| 2 | 2011 | 38 | |
| 3 | 2016 | 30 | |
| 4 | 2022 | 25 | |
| 5 | 2014 | 23 | |
| 6 | 2014 | 18 | |
| 7 | 2010 | 18 | |
| 8 | 2013 | 16 | |
| 9 | 2012 | 14 | |
| 10 | 2014 | 9 | |
| 11 | 2014 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2015 | 6 | |
| 15 | 2022 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Tilman Lingscheid
Tilman Lingscheid is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Pharmacology and Surgery, having authored 24 papers that have together received 279 indexed citations. Recurring topics across this work include Malaria Research and Control (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Infective Endocarditis Diagnosis and Management (4 papers), COVID-19 Clinical Research Studies (4 papers), Antibiotic Resistance in Bacteria (4 papers), Mosquito-borne diseases and control (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Molecular Medicine (52 citations), Infectious Diseases (114 citations), Applied Microbiology and Biotechnology (11 citations), Clinical Biochemistry (28 citations) and Pharmacology (42 citations). Tilman Lingscheid has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Heinz Burgmann, Wolfgang Poeppl, Selma Tobudic, Roberto Plasenzotti, Guido A. Gualdoni, Nicolas Kozakowski, Gerhard J. Zlabinger, Peter Steinberger, Klaus G. Schmetterer and Apostolos P. Georgopoulos. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Travel Medicine, Pharmacology, Infection and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.